94 related articles for article (PubMed ID: 11850980)
1. Complications of in-dwelling venous access devices: a single institution experience.
Burney IA; Khurshaidi N; Akbar MT; Bhatti FN; Siddiqui T; Sophie Z
J Pak Med Assoc; 2001 Dec; 51(12):434-7. PubMed ID: 11850980
[TBL] [Abstract][Full Text] [Related]
2. Use of port-a-cath in cancer patients: a single-center experience.
D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Zahid KF; Furrukh M; Burney IA; Al-Moundhri MS
J Infect Dev Ctries; 2014 Nov; 8(11):1476-82. PubMed ID: 25390061
[TBL] [Abstract][Full Text] [Related]
3. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
[TBL] [Abstract][Full Text] [Related]
4. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
[TBL] [Abstract][Full Text] [Related]
5. Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in pediatric and adult patients.
Bessoud B; de Baere T; Kuoch V; Desruennes E; Cosset MF; Lassau N; Roche A
AJR Am J Roentgenol; 2003 Feb; 180(2):527-32. PubMed ID: 12540466
[TBL] [Abstract][Full Text] [Related]
6. [Complications associated with the placement of subcutaneous central venous access port devices: reasons for removal and complications observed].
Danno K; Ohnishi T; Watanabe A; Ueda M; Yanagawa T; Kim C; Fujita S; Fujita J; Yoshida T; Tono T; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2404-6. PubMed ID: 23268092
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of device-associated infections related to a long-term implantable vascular access device.
Sotir MJ; Lewis C; Bisher EW; Ray SM; Soucie JM; Blumberg HM
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):187-91. PubMed ID: 10100545
[TBL] [Abstract][Full Text] [Related]
8. Prolonged venous access in cancer patients.
Guenier C; Ferreira J; Pector JC
Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
[TBL] [Abstract][Full Text] [Related]
9. [Early and late complications of the use of life-cath type catheters in children with malignancies requiring urgent surgical intervention].
Jaworski W; Bagłaj SM; Sawicz-Birkowska K; Czernik J
Wiad Lek; 1998; 51 Suppl 4():256-61. PubMed ID: 10731979
[TBL] [Abstract][Full Text] [Related]
10. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Al-Baimani K; Hamid RS; Mittal AK; Al-Balushi M; Burney IA; Al-Moundhri MS
Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e103-e109. PubMed ID: 33777430
[TBL] [Abstract][Full Text] [Related]
11. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
[TBL] [Abstract][Full Text] [Related]
12. Complications associated with an implantable vascular access device.
Dillon PA; Foglia RP
J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
[TBL] [Abstract][Full Text] [Related]
13. Acinetobacter infection in Hickman's catheterized patient of multiple myeloma.
Grover JK; Uppal G; Guleria R; Vats V; Raina V
J Assoc Physicians India; 2003 Oct; 51():1026-7. PubMed ID: 14719602
[No Abstract] [Full Text] [Related]
14. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
Schwarz RE; Groeger JS; Coit DG
Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
[TBL] [Abstract][Full Text] [Related]
16. Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients.
Lorch H; Zwaan M; Kagel C; Weiss HD
Cardiovasc Intervent Radiol; 2001; 24(3):180-4. PubMed ID: 11443406
[TBL] [Abstract][Full Text] [Related]
17. [Tunnelled central venous catheters in children with cancer. Removal and duration].
Schrøder H; Malchau E; Larsen LN; Bugge K; Olsen H; Kamperis K
Ugeskr Laeger; 2008 Jan; 170(5):343-7. PubMed ID: 18252163
[TBL] [Abstract][Full Text] [Related]
18. [Port device central venous access in children with chronic renal disease--personal experience].
Szczepańska M; Szprynger K; Stoksik P; Morawiec-Knysak A; Adamczyk P; Ziora K; Oswiecimska J
Wiad Lek; 2006; 59(11-12):814-8. PubMed ID: 17427497
[TBL] [Abstract][Full Text] [Related]
19. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
Nelson BE; Mayer AR; Tseng PC; Schwartz PE
Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
[TBL] [Abstract][Full Text] [Related]
20. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.
Heibl C; Trommet V; Burgstaller S; Mayrbaeurl B; Baldinger C; Koplmüller R; Kühr T; Wimmer L; Thaler J
Eur J Cancer Care (Engl); 2010 Sep; 19(5):676-81. PubMed ID: 19708941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
